Due to the good predictive performance of IP10 in identifying SARS-CoV-positive patients who would undergo a worsening of their clinical conditions [111,116,117], it is not surprising that this chemokine has also been closely investigated in the context of COVID-19, a disease sharing many important pathophysiological features with SARS. Here, CXCL10 is linked to COVID-19.